CTSK and COVID-19: Literature has suggested that MAPK and TNF-α are potential therapeutic targets for COVID-19 [[39], [40], [41], [42]] Another high-scoring compound CHEMBL200004 displayed an inhibitory activity against CTSK in biological detection.